|
Volumn 49, Issue 4, 2003, Pages 459-462
|
In vivo evaluation of the biocompatibility of the totally implantable ventricular assist device (HeartSaver VAD)
a,g b c d e e f a a a a a a a
f
HEALTH CANADA
(Canada)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COAGULATION;
ENZYMES;
HEMOGLOBIN;
IMPLANTS (SURGICAL);
VENTRICULAR ASSIST DEVICE (VAD);
BIOCOMPATIBILITY;
ANTICOAGULANT AGENT;
ASPARTATE AMINOTRANSFERASE;
CREATININE;
HEMOGLOBIN;
HEPARIN;
WARFARIN;
ANIMAL EXPERIMENT;
ANTICOAGULATION;
ARTICLE;
BIOCOMPATIBILITY;
CARDIOPULMONARY BYPASS;
CATTLE;
DRUG MONITORING;
ENDOCARDITIS;
HEART ASSIST DEVICE;
HEMODYNAMICS;
IMPLANTATION;
KIDNEY FUNCTION;
LIVER FUNCTION;
NONHUMAN;
ANIMALS;
CATTLE;
EQUIPMENT DESIGN;
HEART-ASSIST DEVICES;
HEMODYNAMIC PROCESSES;
HEMOGLOBINS;
HUMANS;
MALE;
MATERIALS TESTING;
PLATELET COUNT;
|
EID: 0041807738
PISSN: 10582916
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (10)
|